- Home
- RSVR vs LAB Comparison
RSVR vs LAB Comparison
Compare RSVR & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSVR
- LAB
- Stock Information
- Founded
- RSVR 2007
- LAB 1999
- Country
- RSVR United States
- LAB United States
- Employees
- RSVR N/A
- LAB N/A
- Industry
- RSVR Movies/Entertainment
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- RSVR Consumer Discretionary
- LAB Industrials
- Exchange
- RSVR Nasdaq
- LAB Nasdaq
- Market Cap
- RSVR 528.3M
- LAB 451.0M
- IPO Year
- RSVR N/A
- LAB 2011
- Fundamental
- Price
- RSVR $7.80
- LAB $1.01
- Analyst Decision
- RSVR Strong Buy
- LAB Buy
- Analyst Count
- RSVR 1
- LAB 2
- Target Price
- RSVR $12.50
- LAB $2.50
- AVG Volume (30 Days)
- RSVR 80.2K
- LAB 1.6M
- Earning Date
- RSVR 05-28-2025
- LAB 05-06-2025
- Dividend Yield
- RSVR N/A
- LAB N/A
- EPS Growth
- RSVR 1094.24
- LAB N/A
- EPS
- RSVR 0.12
- LAB N/A
- Revenue
- RSVR $158,705,736.00
- LAB $169,687,000.00
- Revenue This Year
- RSVR $11.41
- LAB N/A
- Revenue Next Year
- RSVR $7.45
- LAB $12.18
- P/E Ratio
- RSVR $65.58
- LAB N/A
- Revenue Growth
- RSVR 9.56
- LAB 33.86
- 52 Week Low
- RSVR $6.56
- LAB $0.92
- 52 Week High
- RSVR $9.83
- LAB $2.65
- Technical
- Relative Strength Index (RSI)
- RSVR 59.56
- LAB 44.66
- Support Level
- RSVR $7.15
- LAB $1.00
- Resistance Level
- RSVR $8.04
- LAB $1.09
- Average True Range (ATR)
- RSVR 0.37
- LAB 0.08
- MACD
- RSVR 0.04
- LAB -0.00
- Stochastic Oscillator
- RSVR 75.26
- LAB 33.33
About RSVR Reservoir Media Inc.
Reservoir Media Inc is an independent music company. The company's segment includes Music Publishing; Recorded Music and others. It generates the maximum of its revenue from the Music Publishing segment.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.